Skip to main content

UC San Diego Department of Dermatology Clinical Trials

Adult Dermatology Research 

Dr. Tissa Hata and Dr. Richard Gallo currently have several ongoing clinical trials, including:

  • New biologic treatments for psoriasis
  • Sponsored trial on atopic dermatitis
  • National Institutues of Health funded study examining the role of probiotic treatments in atopic dermatitis patients.

UC San Diego Dermatology has several groups interested in the study of atopic dermatitis (AD), more commonly known as eczema. Our research interests include ongoing studies into basic immunologic defects present in patients with atopic dermatitis (Gallo Lab) and therapeutic trials at UC San Diego and Rady Children's Hospital.

Psoriasis Research Support

UC San Diego Dermatology is fortunate to be supported by an endowment from the Charles and Anna Stern Foundation for research into psoriasis. Related projects include understanding the immune response of patients with psoriasis compared to atopic dermatitis and clinical trials ongoing at UC San Diego and Rady Children's Hospital.

Skin Cancer Research Collaboration

UC San Diego Dermatology is in the process of expanding our research efforts in the study of cutaneous malignancies such as melanoma, basal cell carcinoma and squamous cell carcinomas. We are assisted in this endeavor by our relationship with UC San Diego Health Moores Cancer Center. Our goals are to establish UC San Diego as a Skin Cancer Center of Excellence.

Trials Now Recruiting Volunteers:

ATOPIC DERMATITIS (ECZEMA)

  • UC San Diego is doing a collaborative work with a sponsor investigate the effect of a month-long application of a lotion on the skin barrier, microbiome, and metabolome in adult patients with atopic dermatitis. Subjects will be financially compensated.
  • UC San Diego sponsored trial to obtain biopsy skin samples and blood draws. This study is a sample collection study with a one-time visit. Subjects will be financially compensated



PSORIASIS

  • UC San Diego is doing a collaborative work with a sponsor to obtain biopsy skin samples and blood draws. This study is a sample collection study with a one-time visit which will be financially compensated.

ACNE

  • UC San Diego is conducting a study to obtain biopsy skin samples of acne present on the back. This is a sample collection study with a one-time visit. Subjects will be financially compensated.
  • UC San Diego is conducting a study to obtain skin swabs, biopsies of participants before, during, and after Accutane treatment. Subjects will be financially compensated.
  • UC San Diego is recruiting patients with acne to participate in a research study for an investigational topical acne treatment. Subjects will be financially compensated.

NOTALGIA PARASTHETICA (BACK ITCH)

  • UC San Diego is recruiting patients who experience a localized back itch due to Notalgia Paresthetica to participate in a research study evaluating an oral medication. Subjects will be financially compensated.

ROSACEA

  • UC San Diego is actively recruiting for healthy control subjects for a collaborative work with a sponsor investigating the effect of a topical medication on rosacea. Qualified healthy subjects will receive financial compensation for a one-time visit where skin swabs will be collected.

Pediatric Dermatology Research

The Pediatric and Adolescent Dermatology Research Group is involved in clinical studies of common and uncommon diseases, including acne, fungal infections, eczema (atopic dermatitis), warts and molluscum and psoriasis. For more information, visit the Rady Children's Hospital Research & Clinical Trials page. 

Questions?

If you would like more information about UC San Diego Dermatalogy clinical trials, please email dermstudies@ucsd.edu or contact:

Olive Osuoji, M.D. 
Clinical Research Fellow
858-657-8390
or 
Faiza Shafiq, MBBS
Clinical Research Associate
858-657-1697

Support Our Work

Your contribution directly supports promising research, critical treatment, or the top-quality training of new generations of dermatologists, and helps us to thoroughly explore innovative avenues in all areas.

Give Now